Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A Retrospective Cohort Study

(1) Background: The efficacy of tocilizumab in COVID-19 has been doubted. The study aimed to investigate factors affecting disease stability and response to tocilizumab among severe COVID-19 patients. (2) Methods: This was a cohort study of 70 severe COVID-19 patients at NMC Royal Hospital, UAE, fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafez, Wael, Abdelrahman, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405062/
https://www.ncbi.nlm.nih.gov/pubmed/36009949
http://dx.doi.org/10.3390/antibiotics11081078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405062/
https://www.ncbi.nlm.nih.gov/pubmed/36009949
http://dx.doi.org/10.3390/antibiotics11081078

Ejemplares similares